Navidea Biopharmaceuticals Inc (NYSE American:NAVB)

0.359
Delayed Data
As of 4:10pm ET
 +0.014 / +4.06%
Today’s Change
0.31
Today|||52-Week Range
0.85
+0.14%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Goldberg Michael M
President & Chief Executive Officer
Gift5/16/2017106,021$0.46$48.8K-21.96%
Regan William J
Senior Vice President
Buy6/29/201720,000$0.53$10.6K-30.33%
Latkin Jed Andrew
Chief Operating & Financial Officer
Buy5/19/201714,159$0.45$6.4K-21.17%
Latkin Jed Andrew
Chief Operating & Financial Officer
Gift5/17/201713,300$0.47$6.3K-21.34%
Latkin Jed Andrew
Chief Operating & Financial Officer
Buy5/22/201711,200$0.45$5.0K-20.13%
Latkin Jed Andrew
Chief Operating & Financial Officer
Buy5/30/20177,600$0.44$3.3K-20.22%
Latkin Jed Andrew
Chief Operating & Financial Officer
Gift5/18/20173,900$0.45$1.8K-20.54%
Fiorino Anthony S
Director
Gift6/30/201750,000$0.00$0.00-29.61%
Greene Mark I
Director
Gift6/30/201750,000$0.00$0.00-29.61%
Rice Michael Yehuda
Director
Gift6/30/201750,000$0.00$0.00-29.61%
Page of 2